Acute promyelocytic leukemia · 3 regimens
Cost vs Efficacy
| Regimen | Biomarker | Cost/cycle ↓ | Cycle | PFS ↕ | OS ↕ | Est. cycles | Course cost ↕ | Evidence |
|---|---|---|---|---|---|---|---|---|
Arsenic trioxide monotherapy N/A - intrathecal component | — | R 0 | — | — | — | — | — | — |
Arsenic trioxide and Idarubicin N/A - intrathecal component | — | R 0 | 60d | — | — | — | — | — |
Tamibarotene monotherapy Variant #01 Partial | — | — | 56d | — | — | — | — | — |
3 of 3 regimens shown